Back to Peptides
Metabolic
Larazotide
Larazotide acetate is an orally delivered peptide that regulates intestinal tight junctions to reduce gut permeability ("leaky gut"). It has advanced through clinical trials as an adjunct therapy for celiac disease and is studied for broader gut-barrier applications.
MetabolicGut HealthBarrierOral
Research Benefits
Regulates intestinal tight junctions
Reduces gut permeability in studies
Advanced through celiac-disease clinical trials
Gut-barrier and inflammation research
Axo's Research Digest
An AI-generated, plain-English overview of what the research explores for Larazotide — and how mature that evidence is.